Financially Strong And High Growth Stocks
Why invest in a stock whose growth outlook that lags behind the market? Investors looking for companies with extraordinary future prospects in terms of profitability and returns should look at the following high-growth stocks. Whether it be a well-known tech stock or a risky small-cap, I believe diversification towards growth can add value to your current holdings. Below I’ve compiled a list of stocks with a bright future ahead.
Altura Mining Limited (ASX:AJM)
Altura Mining Limited engages in the exploration and development of mineral properties in Australia, Indonesia, and internationally. Altura Mining is headed by CEO James Brown. With a current market cap of AUD A$709.32M, we can put AJM in the small-cap category
Thinking of investing in AJM? I recommend researching its fundamentals here.
Tawana Resources NL (ASX:TAW)
Tawana Resources NL engages in the exploration and development of mineral properties in Western Australia, Namibia, and Liberia. Tawana Resources NL was founded in 1998 and with the company’s market capitalisation at AUD A$201.71M, we can put it in the small-cap category. Extreme optimism for TAW, as market analysts projected an outstanding earnings growth rate of 93.68% for the stock, supported by an equally strong sales. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 25.87%. TAW ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Interested to learn more about TAW? Take a look at its other fundamentals here.
Osprey Medical, Inc. (ASX:OSP)
Osprey Medical, Inc., a medical device company, focuses on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures in the United States. Osprey Medical was established in 2005 and with the company’s market cap sitting at AUD A$145.93M, it falls under the small-cap group. An outstanding 75.32% earnings growth is forecasted for OSP, driven by strong underlying sales growth over the next few years. It appears that OSP’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. Moreover, the 21.24% growth in operating cash flows shows that a decent part of earnings is driven by robust cash generation from operational activities, not one-off or non-core activities. OSP’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Should you add OSP to your portfolio? Other fundamental factors you should also consider can be found here.
For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
